These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23998076)

  • 21. Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial.
    Sangha R; Davies AM; Lara PN; Mack PC; Beckett LA; Hesketh PJ; Lau D; Li T; Perkins N; Gandara DR
    J Thorac Oncol; 2011 Dec; 6(12):2112-9. PubMed ID: 21892109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.
    Benzekry S; Hahnfeldt P
    J Theor Biol; 2013 Oct; 335():235-44. PubMed ID: 23850479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic optimization of chemotherapy outpatient scheduling with uncertainty.
    Hahn-Goldberg S; Carter MW; Beck JC; Trudeau M; Sousa P; Beattie K
    Health Care Manag Sci; 2014 Dec; 17(4):379-92. PubMed ID: 24477637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery.
    Abratt RP; Sandler A; Crinò L; Steward WP; Shepherd FA; Green MR; Nguyen B; Peters GJ
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):35-43. PubMed ID: 9728583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical treatment guide for dose individualisation in cancer chemotherapy.
    Canal P; Chatelut E; Guichard S
    Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A short-term operating room surgery scheduling problem integrating multiple nurses roster constraints.
    Xiang W; Yin J; Lim G
    Artif Intell Med; 2015 Feb; 63(2):91-106. PubMed ID: 25563674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia.
    Henrich A; Joerger M; Kraff S; Jaehde U; Huisinga W; Kloft C; Parra-Guillen ZP
    J Pharmacol Exp Ther; 2017 Aug; 362(2):347-358. PubMed ID: 28600397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal control methods for drug delivery in cancerous tumour by anti-angiogenic therapy and chemotherapy.
    Khalili P; Zolatash S; Vatankhah R; Taghvaei S
    IET Syst Biol; 2021 Feb; 15(1):14-25. PubMed ID: 33491873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acuity-based nurse assignment and patient scheduling in oncology clinics.
    Liang B; Turkcan A
    Health Care Manag Sci; 2016 Sep; 19(3):207-26. PubMed ID: 25595434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.
    Shaw AT; Felip E; Bauer TM; Besse B; Navarro A; Postel-Vinay S; Gainor JF; Johnson M; Dietrich J; James LP; Clancy JS; Chen J; Martini JF; Abbattista A; Solomon BJ
    Lancet Oncol; 2017 Dec; 18(12):1590-1599. PubMed ID: 29074098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
    Tod MM; Padoin C; Petitjean O
    Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intraperitoneal mitomycin C.
    van Ruth S; Verwaal VJ; Zoetmulder FA
    Surg Oncol Clin N Am; 2003 Jul; 12(3):771-80. PubMed ID: 14567030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.
    Terterov IN; Chubenko VA; Knyazev NA; Klimenko VV; Bogdanov AA; Moiseyenko VM; Bogdanov AA
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):867-878. PubMed ID: 34351468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
    Bishop JF
    Lung Cancer; 1995 Jun; 12 Suppl 2():S53-61. PubMed ID: 7551950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An improved gray wolf optimization to solve the multi-objective tugboat scheduling problem.
    Yao P; Duan X; Tang J
    PLoS One; 2024; 19(2):e0296966. PubMed ID: 38408052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
    Dumont C; Mentré F; Gaynor C; Brendel K; Gesson C; Chenel M
    Clin Pharmacokinet; 2013 Jan; 52(1):43-57. PubMed ID: 23212609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and implementation of an adaptive fuzzy sliding mode controller for drug delivery in treatment of vascular cancer tumours and its optimisation using genetic algorithm tool.
    Ghasemabad ES; Zamani I; Tourajizadeh H; Mirhadi M; Zarandi ZG
    IET Syst Biol; 2022 Dec; 16(6):201-219. PubMed ID: 36181296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
    Stretcher BN
    Clin Pharmacokinet; 1995 Jul; 29(1):46-65. PubMed ID: 7586898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
    Infante JR; Fecher LA; Falchook GS; Nallapareddy S; Gordon MS; Becerra C; DeMarini DJ; Cox DS; Xu Y; Morris SR; Peddareddigari VG; Le NT; Hart L; Bendell JC; Eckhardt G; Kurzrock R; Flaherty K; Burris HA; Messersmith WA
    Lancet Oncol; 2012 Aug; 13(8):773-81. PubMed ID: 22805291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple model predictive control for optimal drug administration of mixed immunotherapy and chemotherapy of tumours.
    Sharifi N; Ozgoli S; Ramezani A
    Comput Methods Programs Biomed; 2017 Jun; 144():13-19. PubMed ID: 28494997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.